Monoclonal gammopathy of undetermined significance (MGUS) is when small amounts of antibodies called monoclonal antibodies (or M antibodies) are found in your blood. Normally, the plasma cells in your ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...

A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” Multiple ...

MGUS represents clonal plasma-cell production of M-protein without CRAB features, so chemotherapy or radiotherapy is not indicated outside progression. Risk stratification hinges on M-protein burden, ...

(WASHINGTON, January 12, 2024) – Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple ...

A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, "Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma." Multiple ...

Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy Patients with smoldering MM with ...

*p-value from Fisher’s exact test. Abbreviations: MGUS=Monoclonal Gammopathy of undetermined significance; MM=Multiple Myeloma; DM=Diabetes Mellitus. This is an ASCO Meeting Abstract from the 2024 ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

Please provide your email address to receive an email when new articles are posted on . Individuals with obesity and heavy smokers had higher rates of MGUS, a precursor to multiple myeloma. Highly ...